Marshall Wace North America’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $84.5M | Buy |
|
|||||
|
2021
Q2 | $66.6M | Sell |
|
|||||
|
2021
Q1 | $56.1M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.6M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.68M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $74K | Sell |
|
|||||
|
2018
Q4 | $173K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $6.43M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $6.28M | Sell |
|
|||||
|
2017
Q2 | $11M | Sell |
|
|||||
|
2017
Q1 | $39.4M | Buy |
|